ICU · SeaStar Medical Holding Corp
$3.77
+0.03 (+0.80%)
At close · Jul 24
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does *not* believe that its cash on hand will be sufficient to enable it to fund its operations, including clinical trial expenses and capital expenditure requirements for at least *12* months from the issuance of these unaudited condensed consolidated financial statements. The Company believes that these conditions raise substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 13, 2026
Market Cap
$14.99M
Shares
4.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.74
Open$3.90
Day$3.68–3.95
52W$2.07–12.50
Avg vol 30d103K
Short int139K · 3.5% float · 1.0d
Short vol59%
Last earningsJun 30, 2026
DataMar 2021–Jul 2026
Filing10-Q · May 13
Up next
Next earnings call
Sep 29, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+3%
above
Price vs 50-day avg
−2%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
16%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+21%
trailing
6-month return
+60%
trailing
YTD return
+56%
this year
Relative strength
+54%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Flat
2 of 17 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.48% of float · ▲ +69.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — 13F breadth
Squeeze score
53
elevated · 0–100
Fundamentals
Revenue growth
+814%
Y/Y
Gross margin
96%
contracting
EPS growth
+78%
Y/Y
Balance sheet
$4.1M
net debt
Quant / Vol
risk profile
Volatility
121%
annualized · 1-yr
Max drawdown
−82%
past year
ATR
10.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+3%
Bullish
Price vs 50-day avg
−2%
Neutral
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
16%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Flat
2 of 17 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.48% of float · ▲ +69.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $2
Now $4 · 16%
52-wk high $13
vs 200-day avg +3%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ICU
this stock
SeaStar Medical Holding Corp
|
$14.99M | +55.8% | +814.1% | — | 3.5% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ICU | -11.4% | +21.0% | +60.2% | +1.9% | +55.8% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -9.7% | +20.4% | +53.8% | +3.1% | +47.6% |